Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The AML1 gene encodes a transcription factor that, together with its heterodimeric partner CBFB, regulates a number of target genes that are essential for normal hemopoiesis. In acute myeloid leukemia (AML), AML1 is disrupted not only by chromosomal translocations but also by mutations in the runt domain, which binds both DNA and CBFB. Acquired mutations have been described predominantly in the AML FAB type M0. To date, most patients appear to have biallelic disease, suggesting a complete lack of normal AML1 function. Inherited loss of function mutations thought to lead to haploinsufficiency also have been described in patients who have a familial disorder with predisposition to AML (FPD/AML), indicating the role of AML1 in megakaryopoiesis. Using single‐strand conformation polymorphism analysis, we studied the AML1 runt domain in 41 patients with M0 AML and identified potentially pathologic mutations in five (12%). Biallelic disease could be confirmed in only one patient, using loss of heterozygosity studies. At least three of the mutations would lead to truncated proteins similar to those reported in FPD/AML, suggesting that haploinsufficiency plays a role in the pathogenesis of this minimally differentiated type of leukemia. The incidence of acquired mutations in AML patients with acute megakaryoblastic leukemia (FAB type M7) was the same as that reported in other non‐M0 patients, with only one mutation detected in 20 (5%) patients studied. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178 · cited 1×
“Evidence of the critical role of AML1 in hemopoiesis has come from AML1 knock-out mice, which are embryonic lethal and show a lack of fetal hemopoietic cells (Okuda et al., 1996; Wang et al., 1996).”
BackgroundSong, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100 · cited 4×
“For each patient, fragments encompassing exons 3, 4, and 5 were amplified using intronic polymerase chain reaction (PCR) primers previously published by Song et al. (1999).”
BackgroundMethodInfluentialZhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“It activates a number of genes in immature myeloid cells, such as myeloperoxidase and neutrophil elastase (Nuchprayoon et al., 1994), and interacts with the transcription factor C/EBP , which is essential for granulocytic differentiation (Zhang et al., 1996, 1997; Pabst et al., 2001a).”
BackgroundPabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901 · cited 2×
“E-mail: stephenl@icr.ac.uk Received 18 June 2001; Accepted 18 September 2001 Published online 1 February 2002 GENES, CHROMOSOMES & CANCER 34:24–32 (2002) DOI 10.1002/gcc.10031 © 2002 Wiley-Liss, Inc. diated through its association with and downregulation of C/EBP (Pabst et al., 2001b).”
BackgroundInfluentialMiyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872 · cited 1×
“AML1, located on chromosome 21, was first identified as the fusion partner to the ETO gene created by the t(8;21)(q22; q22) chromosomal translocation (Miyoshi et al., 1991), which occurs in approximately 10–15% of patients with adult acute myeloid leukemia (AML).”
BackgroundErickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631 · cited 2×
“segmentation gene runt (Daga et al., 1992; Erickson et al., 1992) and to two other genes that encode”
BackgroundAML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463 · cited 3×
“E-mail: stephenl@icr.ac.uk Received 18 June 2001; Accepted 18 September 2001 Published online 1 February 2002 GENES, CHROMOSOMES & CANCER 34:24–32 (2002) DOI 10.1002/gcc.10031 © 2002 Wiley-Liss, Inc. diated through its association with and downregulation of C/EBP (Pabst et al., 2001b).”
BackgroundInfluentialZhang, D.-E., Hetherington, C. J., Meyers, S., Rhoades, K. L., Larson, C. J., Chen, H.-M., Hiebert, S. W., & Tenen, D. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1231 · Cited by 396 · cited 1×
“It activates a number of genes in immature myeloid cells, such as myeloperoxidase and neutrophil elastase (Nuchprayoon et al., 1994), and interacts with the transcription factor C/EBP , which is essential for granulocytic differentiation (Zhang et al., 1996, 1997; Pabst et al., 2001a).”
BackgroundLevanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., & Groner, Y. (1994) · Genomics · doi:10.1006/geno.1994.1519 · Cited by 391
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368 · cited 2×
“codes for a transactivation domain that is lost in the t(8;21) (Meyers et al., 1995).”
BackgroundNuchprayoon, I., Meyers, S., Scott, L. M., Suzow, J., Hiebert, S., & Friedman, A. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5558 · Cited by 296
Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270 · cited 2×
“Overexpression of AML1ETO inhibits granulocyte colony-stimulating factor–induced differentiation of myeloid progenitor cells (Westendorf et al., 1998), which may be me- Supported by: Kay Kendall Leukaemia Fund; Leukaemia Research Fund.”
BackgroundAlternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia
Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soceda, E., & Ohkl, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2762 · Cited by 264 · cited 1×
“The AML1 gene spans approximately 260 kb of DNA and contains nine major exons (Miyoshi et al., 1995; Levanon et al., 2001).”
BackgroundPreudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., & Hirai, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07008.x · Cited by 224 · cited 2×
“…(AML1a) that truncates the protein and deletes the transactivation domain have been reported in AML patients, and overexpression of AML1a dominantly suppresses transcriptional activation by the full-length protein and inhibits granulocytic differentiation in response to G-CSF (Tanaka et al., 1995).”
BackgroundMeyers, S., Downing, J. R., & Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6336-6345.1993 · Cited by 94 · cited 3×
“conformation that allows AML1 binding to both DNA and CBFB (Meyers et al., 1993).”
BackgroundInfluential
Cited by
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3280 · Cited by 462
Gaidzik, V. I., Bullinger, L., Schlenk, R. F., Zimmermann, A. S., Röck, J., Paschka, P., Corbacioglu, A., Krauter, J., Schlegelberger, B., Ganser, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7926 · Cited by 456
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
Renneville, A., Roumier, C., Biggio, V, Nibourel, O., Boissel, N., Fenaux, P., & Preudhomme, C. (2008) · Leukemia · doi:10.1038/leu.2008.19 · Cited by 351
Tang, J.-L., Hou, H.-A., Chen, C.-Y., Liu, C.-Y., Chou, W.-C., Tseng, M.-H., Huang, C.-F., Lee, F.-Y., Liu, M.-C., Yao, M., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223784 · Cited by 344
Metadata
- Authors
- Langabeer, S. E., Gale, R. E., Rollinson, S. J., Morgan, G. J., & Linch, D. C.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 34
- Issue
- 1
- Pages
- 24-32
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2067835091
- Cited by
- 57
- References
- 17
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.